GROUP ONE TRADING, L.P. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is and the CUSIP is 462260900. A total of 4 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,693,235
+13.0%
811,700
+74.8%
0.01%
+20.0%
Q2 2023$3,268,672
+84.0%
464,300
+59.7%
0.01%
+66.7%
Q1 2023$1,776,788
-49.0%
290,800
-46.6%
0.01%
-25.0%
Q4 2022$3,481,272
+56.4%
544,800
+134.4%
0.01%
+100.0%
Q3 2022$2,226,000
-32.6%
232,400
-22.4%
0.00%
-20.0%
Q2 2022$3,305,000
-51.0%
299,400
-26.1%
0.01%
-28.6%
Q1 2022$6,747,000
+51.4%
405,200
+73.6%
0.01%
+75.0%
Q4 2021$4,456,000
+115.6%
233,400
+178.5%
0.00%
+100.0%
Q3 2021$2,067,000
-86.7%
83,800
-86.0%
0.00%
-89.5%
Q2 2021$15,596,000
+298.6%
599,400
+385.0%
0.02%
+216.7%
Q1 2021$3,913,000
-57.3%
123,600
-37.4%
0.01%
-62.5%
Q4 2020$9,155,000
+205.3%
197,300
+116.6%
0.02%
+77.8%
Q3 2020$2,999,000
-66.3%
91,100
-71.9%
0.01%
-78.0%
Q2 2020$8,908,000
-3.5%
324,500
+5.2%
0.04%
-45.3%
Q1 2020$9,235,000
+134.3%
308,500
+116.6%
0.08%
+177.8%
Q4 2019$3,942,000
-0.3%
142,400
-34.5%
0.03%
-15.6%
Q3 2019$3,955,000
+650.5%
217,300
+910.7%
0.03%
+540.0%
Q2 2019$527,000
+454.7%
21,500
+115.0%
0.01%
+400.0%
Q1 2019$95,000
+5.6%
10,000
-2.0%
0.00%0.0%
Q4 2018$90,000
-66.5%
10,200
-57.3%
0.00%
-50.0%
Q3 2018$269,000
+136.0%
23,900
+168.5%
0.00%
+100.0%
Q2 2018$114,000
-82.3%
8,900
-76.6%
0.00%
-83.3%
Q1 2018$644,000
+153.5%
38,100
+20.2%
0.01%
+200.0%
Q4 2017$254,000
+44.3%
31,700
+32.1%
0.00%0.0%
Q2 2017$176,00024,0000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 200,000$2,208,0000.13%
GROUP ONE TRADING, L.P. 299,400$3,305,0000.01%
SIMPLEX TRADING, LLC 223,700$2,469,0000.00%
JANE STREET GROUP, LLC 245,500$2,710,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders